ANI Pharmaceuticals
ANIP
ANIP
117 hedge funds and large institutions have $239M invested in ANI Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 48 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $252M → $239M (-$13.7M)
44% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 48
45% less call options, than puts
Call options by funds: $560K | Put options by funds: $1.01M
Holders
117
Holding in Top 10
1
Calls
$560K
Puts
$1.01M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$3.1M | |
| 3 | +$2.44M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$2.3M |
| 5 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
+$2.12M |
Top Sellers
| 1 | -$2M | |
| 2 | -$1.66M | |
| 3 | -$1.47M | |
| 4 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
-$1.29M |
| 5 |
BlackRock
New York
|
-$1.1M |